2023-2029 Global Medical Autologous Biologics Industry Research & Trends Analysis Report
2023-2029 Global Medical Autologous Biologics Industry Research & Trends Analysis Report
The Medical Autologous Biologics Market report highlights technological advancements, investment opportunities, and regulatory frameworks shaping the industry landscape through 2030.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Research, the global market for Medical Autologous Biologics should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Medical Autologous Biologics market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Medical Autologous Biologics market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Adipose Tissue segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospitals has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Medical Autologous Biologics include Vericel Corporation, BioTime, Pharmicell, BrainStorm Cell Therapeutics, Opexa Therapeutics, Sartorius, Neostem, Dendreon Corporation and Regenexx, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Medical Autologous Biologics. Report Highlights:
(1) Global Medical Autologous Biologics market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Medical Autologous Biologics market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Medical Autologous Biologics market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Medical Autologous Biologics segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Medical Autologous Biologics segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Medical Autologous Biologics, capacity, production and trends.
(7) Medical Autologous Biologics industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Adipose Tissue
Plasma
Others
Market segment by application, can be divided into
Hospitals
Research Center
Others
Market segment by players, this report covers
Vericel Corporation
BioTime
Pharmicell
BrainStorm Cell Therapeutics
Opexa Therapeutics
Sartorius
Neostem
Dendreon Corporation
Regenexx
Cytori Therapeutics
1 Market Overview
1.1 Medical Autologous Biologics Definition
1.2 Global Medical Autologous Biologics Market Size and Forecast
1.2.1 By Revenue, Global Medical Autologous Biologics Market Size, 2018-2029
1.2.2 By Sales Volume, Global Medical Autologous Biologics Market Size, 2018-2029
1.2.3 Global Medical Autologous Biologics Price Trend, 2018-2029
1.3 China Medical Autologous Biologics Market Size and Forecast
1.3.1 By Revenue, China Medical Autologous Biologics Market Size, 2018-2029
1.3.2 By Sales Volume, China Medical Autologous Biologics Market Size, 2018-2029
1.3.3 China Medical Autologous Biologics Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Medical Autologous Biologics Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Medical Autologous Biologics Share in Global Market, 2018-2029
1.4.3 Medical Autologous Biologics Market Size: China VS Global, 2018-2029
1.5 Medical Autologous Biologics Market Dynamics
1.5.1 Medical Autologous Biologics Market Drivers
1.5.2 Medical Autologous Biologics Market Restraints
1.5.3 Medical Autologous Biologics Industry Trends
1.5.4 Medical Autologous Biologics Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Medical Autologous Biologics Revenue by Company, 2018-2023
2.2 Global Medical Autologous Biologics Sales Volume by Company, 2018-2023
2.3 Global Medical Autologous Biologics Price by Company, 2018-2023
2.4 Global Medical Autologous Biologics Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Medical Autologous Biologics Concentration Ratio
2.6 Global Medical Autologous Biologics Mergers & Acquisitions, Expansion Plans
2.7 Global Medical Autologous Biologics Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Medical Autologous Biologics Revenue by Company, 2018-2023
3.2 China Medical Autologous Biologics Sales Volume by Company, 2018-2023
3.3 China Medical Autologous Biologics Medical Autologous Biologics Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Medical Autologous Biologics Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Medical Autologous Biologics Domestic VS Export
3.6 China Market, Medical Autologous Biologics Import & Export
3.6.1 China Market, Medical Autologous Biologics Import & Export, 2018-2029
3.6.2 China Medical Autologous Biologics Import & Export Trends
3.6.3 Main Sources of China Medical Autologous Biologics Import
3.6.4 Export Destination of China Medical Autologous Biologics
4 Medical Autologous Biologics Production by Region
4.1 Global Medical Autologous Biologics Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Medical Autologous Biologics Manufacturers
4.3 Global Major Manufacturers, Medical Autologous Biologics Capacity Expansion and Future Plans
4.4 Global Medical Autologous Biologics Capacity by Region
4.5 Global Medical Autologous Biologics Production by Region
4.5.1 Global Medical Autologous Biologics Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Medical Autologous Biologics Production by Region, 2018-2023
4.5.3 Global Medical Autologous Biologics Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Medical Autologous Biologics Industry Chain
5.2 Medical Autologous Biologics Upstream Analysis
5.2.1 Medical Autologous Biologics Core Raw Materials
5.2.2 Main Manufacturers of Medical Autologous Biologics Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Medical Autologous Biologics Production Mode
5.6 Medical Autologous Biologics Procurement Model
5.7 Medical Autologous Biologics Industry Sales Model and Sales Channels
5.7.1 Medical Autologous Biologics Sales Model
5.7.2 Medical Autologous Biologics Typical Distributors
6 Sights by Type
6.1 Medical Autologous Biologics Classification
6.1.1 Adipose Tissue
6.1.2 Plasma
6.1.3 Others
6.2 By Type, Global Medical Autologous Biologics Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Medical Autologous Biologics Revenue, 2018-2029
6.4 By Type, Global Medical Autologous Biologics Sales Volume, 2018-2029
6.5 By Type, Global Medical Autologous Biologics Price, 2018-2029
7 Sights by Application
7.1 Medical Autologous Biologics Segment by Application
7.1.1 Hospitals
7.1.2 Research Center
7.1.3 Others
7.2 By Application, Global Medical Autologous Biologics Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Medical Autologous Biologics Revenue, 2018-2029
7.4 By Application, Global Medical Autologous Biologics Sales Volume, 2018-2029
7.5 By Application, Global Medical Autologous Biologics Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Medical Autologous Biologics Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Medical Autologous Biologics Revenue, 2018-2029
8.3 By Region, Global Medical Autologous Biologics Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Medical Autologous Biologics Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Medical Autologous Biologics Market Size Market Share
8.5 Europe
8.5.1 Europe Medical Autologous Biologics Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Medical Autologous Biologics Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Medical Autologous Biologics Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Medical Autologous Biologics Market Size Market Share
8.7 South America
8.7.1 South America Medical Autologous Biologics Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Medical Autologous Biologics Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Medical Autologous Biologics Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Medical Autologous Biologics Revenue, 2018-2029
9.3 By Country, Global Medical Autologous Biologics Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Medical Autologous Biologics Market Size, 2018-2029
9.4.2 By Company, U.S. Medical Autologous Biologics Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Medical Autologous Biologics Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Medical Autologous Biologics Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Medical Autologous Biologics Market Size, 2018-2029
9.5.2 By Company, Europe Medical Autologous Biologics Sales Volume Market Share, 2022
9.5.3 By Type, Europe Medical Autologous Biologics Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Medical Autologous Biologics Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Medical Autologous Biologics Market Size, 2018-2029
9.6.2 By Company, China Medical Autologous Biologics Sales Volume Market Share, 2022
9.6.3 By Type, China Medical Autologous Biologics Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Medical Autologous Biologics Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Medical Autologous Biologics Market Size, 2018-2029
9.7.2 By Company, Japan Medical Autologous Biologics Sales Volume Market Share, 2022
9.7.3 By Type, Japan Medical Autologous Biologics Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Medical Autologous Biologics Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Medical Autologous Biologics Market Size, 2018-2029
9.8.2 By Company, South Korea Medical Autologous Biologics Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Medical Autologous Biologics Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Medical Autologous Biologics Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Medical Autologous Biologics Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Medical Autologous Biologics Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Medical Autologous Biologics Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Medical Autologous Biologics Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Medical Autologous Biologics Market Size, 2018-2029
9.10.2 By Company, India Medical Autologous Biologics Sales Volume Market Share, 2022
9.10.3 By Type, India Medical Autologous Biologics Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Medical Autologous Biologics Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Medical Autologous Biologics Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Medical Autologous Biologics Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Medical Autologous Biologics Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Medical Autologous Biologics Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Vericel Corporation
10.1.1 Vericel Corporation Company Information, Head Office, Market Area and Industry Position
10.1.2 Vericel Corporation Medical Autologous Biologics Models, Specifications and Application
10.1.3 Vericel Corporation Medical Autologous Biologics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Vericel Corporation Company Profile and Main Business
10.1.5 Vericel Corporation Recent Developments
10.2 BioTime
10.2.1 BioTime Company Information, Head Office, Market Area and Industry Position
10.2.2 BioTime Medical Autologous Biologics Models, Specifications and Application
10.2.3 BioTime Medical Autologous Biologics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 BioTime Company Profile and Main Business
10.2.5 BioTime Recent Developments
10.3 Pharmicell
10.3.1 Pharmicell Company Information, Head Office, Market Area and Industry Position
10.3.2 Pharmicell Medical Autologous Biologics Models, Specifications and Application
10.3.3 Pharmicell Medical Autologous Biologics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Pharmicell Company Profile and Main Business
10.3.5 Pharmicell Recent Developments
10.4 BrainStorm Cell Therapeutics
10.4.1 BrainStorm Cell Therapeutics Company Information, Head Office, Market Area and Industry Position
10.4.2 BrainStorm Cell Therapeutics Medical Autologous Biologics Models, Specifications and Application
10.4.3 BrainStorm Cell Therapeutics Medical Autologous Biologics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 BrainStorm Cell Therapeutics Company Profile and Main Business
10.4.5 BrainStorm Cell Therapeutics Recent Developments
10.5 Opexa Therapeutics
10.5.1 Opexa Therapeutics Company Information, Head Office, Market Area and Industry Position
10.5.2 Opexa Therapeutics Medical Autologous Biologics Models, Specifications and Application
10.5.3 Opexa Therapeutics Medical Autologous Biologics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Opexa Therapeutics Company Profile and Main Business
10.5.5 Opexa Therapeutics Recent Developments
10.6 Sartorius
10.6.1 Sartorius Company Information, Head Office, Market Area and Industry Position
10.6.2 Sartorius Medical Autologous Biologics Models, Specifications and Application
10.6.3 Sartorius Medical Autologous Biologics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Sartorius Company Profile and Main Business
10.6.5 Sartorius Recent Developments
10.7 Neostem
10.7.1 Neostem Company Information, Head Office, Market Area and Industry Position
10.7.2 Neostem Medical Autologous Biologics Models, Specifications and Application
10.7.3 Neostem Medical Autologous Biologics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Neostem Company Profile and Main Business
10.7.5 Neostem Recent Developments
10.8 Dendreon Corporation
10.8.1 Dendreon Corporation Company Information, Head Office, Market Area and Industry Position
10.8.2 Dendreon Corporation Medical Autologous Biologics Models, Specifications and Application
10.8.3 Dendreon Corporation Medical Autologous Biologics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Dendreon Corporation Company Profile and Main Business
10.8.5 Dendreon Corporation Recent Developments
10.9 Regenexx
10.9.1 Regenexx Company Information, Head Office, Market Area and Industry Position
10.9.2 Regenexx Medical Autologous Biologics Models, Specifications and Application
10.9.3 Regenexx Medical Autologous Biologics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Regenexx Company Profile and Main Business
10.9.5 Regenexx Recent Developments
10.10 Cytori Therapeutics
10.10.1 Cytori Therapeutics Company Information, Head Office, Market Area and Industry Position
10.10.2 Cytori Therapeutics Medical Autologous Biologics Models, Specifications and Application
10.10.3 Cytori Therapeutics Medical Autologous Biologics Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Cytori Therapeutics Company Profile and Main Business
10.10.5 Cytori Therapeutics Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Medical Autologous Biologics Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Medical Autologous Biologics Market Restraints
Table 3. Medical Autologous Biologics Market Trends
Table 4. Medical Autologous Biologics Industry Policy
Table 5. Global Medical Autologous Biologics Revenue by Company, 2018-2023, US$ million
Table 6. Global Medical Autologous Biologics Revenue Market Share by Company, 2018-2023
Table 7. Global Medical Autologous Biologics Sales Volume by Company, 2018-2023, (Kg)
Table 8. Global Medical Autologous Biologics Sales Volume Market Share by Company, 2018-2023
Table 9. Global Medical Autologous Biologics Price by Company, 2018-2023, (US$/g)
Table 10. Global Medical Autologous Biologics Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Medical Autologous Biologics Mergers & Acquisitions, Expansion Plans
Table 12. Global Medical Autologous Biologics Manufacturers Product Type
Table 13. China Medical Autologous Biologics Revenue by Company, 2018-2023, US$ million
Table 14. China Medical Autologous Biologics Revenue Market Share by Company, 2018-2023
Table 15. China Medical Autologous Biologics Sales Volume by Company, 2018-2023, (Kg)
Table 16. China Medical Autologous Biologics Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Medical Autologous Biologics Production, Sales, Import and Export, 2018-2029, (Kg)
Table 18. China Medical Autologous Biologics Import & Export Trends
Table 19. Main Sources of China Medical Autologous Biologics Import
Table 20. Export Destination of China Medical Autologous Biologics
Table 21. Global Headquarters and Manufacturing Base of Medical Autologous Biologics Manufacturers
Table 22. Global Major Manufacturers, Medical Autologous Biologics Capacity Expansion and Future Plans
Table 23. Global Medical Autologous Biologics Production & Forecast by Region, 2018 VS 2022 VS 2029, (Kg)
Table 24. Global Medical Autologous Biologics Production by Region, 2018-2023, (Kg)
Table 25. Global Medical Autologous Biologics Production Forecast by Region, 2023-2029, (Kg)
Table 26. Global Key Players of Medical Autologous Biologics Upstream (Raw Materials)
Table 27. Global Medical Autologous Biologics Typical Customers
Table 28. Medical Autologous Biologics Typical Distributors
Table 29. By Type, Global Medical Autologous Biologics Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Medical Autologous Biologics Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Medical Autologous Biologics Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Medical Autologous Biologics Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Medical Autologous Biologics Sales Volume, 2018-2029, (Kg)
Table 34. By Country, Global Medical Autologous Biologics Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Medical Autologous Biologics Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Medical Autologous Biologics Revenue Market Share, 2018-2029
Table 37. By Country, Global Medical Autologous Biologics Sales Volume, 2018-2029, (Kg)
Table 38. By Country, Global Medical Autologous Biologics Sales Volume Market Share, 2018-2029
Table 39. Vericel Corporation Company Information, Head Office, Market Area and Industry Position
Table 40. Vericel Corporation Medical Autologous Biologics Models, Specifications and Application
Table 41. Vericel Corporation Medical Autologous Biologics Sales Volume (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2018-2023
Table 42. Vericel Corporation Company Profile and Main Business
Table 43. Vericel Corporation Recent Developments
Table 44. BioTime Company Information, Head Office, Market Area and Industry Position
Table 45. BioTime Medical Autologous Biologics Models, Specifications and Application
Table 46. BioTime Medical Autologous Biologics Sales Volume (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2018-2023
Table 47. BioTime Company Profile and Main Business
Table 48. BioTime Recent Developments
Table 49. Pharmicell Company Information, Head Office, Market Area and Industry Position
Table 50. Pharmicell Medical Autologous Biologics Models, Specifications and Application
Table 51. Pharmicell Medical Autologous Biologics Sales Volume (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2018-2023
Table 52. Pharmicell Company Profile and Main Business
Table 53. Pharmicell Recent Developments
Table 54. BrainStorm Cell Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 55. BrainStorm Cell Therapeutics Medical Autologous Biologics Models, Specifications and Application
Table 56. BrainStorm Cell Therapeutics Medical Autologous Biologics Sales Volume (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2018-2023
Table 57. BrainStorm Cell Therapeutics Company Profile and Main Business
Table 58. BrainStorm Cell Therapeutics Recent Developments
Table 59. Opexa Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 60. Opexa Therapeutics Medical Autologous Biologics Models, Specifications and Application
Table 61. Opexa Therapeutics Medical Autologous Biologics Sales Volume (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2018-2023
Table 62. Opexa Therapeutics Company Profile and Main Business
Table 63. Opexa Therapeutics Recent Developments
Table 64. Sartorius Company Information, Head Office, Market Area and Industry Position
Table 65. Sartorius Medical Autologous Biologics Models, Specifications and Application
Table 66. Sartorius Medical Autologous Biologics Sales Volume (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2018-2023
Table 67. Sartorius Company Profile and Main Business
Table 68. Sartorius Recent Developments
Table 69. Neostem Company Information, Head Office, Market Area and Industry Position
Table 70. Neostem Medical Autologous Biologics Models, Specifications and Application
Table 71. Neostem Medical Autologous Biologics Sales Volume (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2018-2023
Table 72. Neostem Company Profile and Main Business
Table 73. Neostem Recent Developments
Table 74. Dendreon Corporation Company Information, Head Office, Market Area and Industry Position
Table 75. Dendreon Corporation Medical Autologous Biologics Models, Specifications and Application
Table 76. Dendreon Corporation Medical Autologous Biologics Sales Volume (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2018-2023
Table 77. Dendreon Corporation Company Profile and Main Business
Table 78. Dendreon Corporation Recent Developments
Table 79. Regenexx Company Information, Head Office, Market Area and Industry Position
Table 80. Regenexx Medical Autologous Biologics Models, Specifications and Application
Table 81. Regenexx Medical Autologous Biologics Sales Volume (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2018-2023
Table 82. Regenexx Company Profile and Main Business
Table 83. Regenexx Recent Developments
Table 84. Cytori Therapeutics Company Information, Head Office, Market Area and Industry Position
Table 85. Cytori Therapeutics Medical Autologous Biologics Models, Specifications and Application
Table 86. Cytori Therapeutics Medical Autologous Biologics Sales Volume (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin, 2018-2023
Table 87. Cytori Therapeutics Company Profile and Main Business
Table 88. Cytori Therapeutics Recent Developments
List of Figure
Figure 1. Medical Autologous Biologics Picture
Figure 2. By Revenue, Global Medical Autologous Biologics Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Medical Autologous Biologics Market Size and Forecast, 2018-2029, (Kg)
Figure 4. Global Medical Autologous Biologics Price Trend, 2018-2029, (US$/g)
Figure 5. By Revenue, China Medical Autologous Biologics Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Medical Autologous Biologics Market Size and Forecast, 2018-2029, (Kg)
Figure 7. China Medical Autologous Biologics Price Trend, 2018-2029 (US$/g)
Figure 8. By Revenue, China Medical Autologous Biologics Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Medical Autologous Biologics Share of Global Market, 2018-2029
Figure 10. Global Medical Autologous Biologics Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Medical Autologous Biologics Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Medical Autologous Biologics Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Medical Autologous Biologics Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Medical Autologous Biologics Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Medical Autologous Biologics Domestic VS Export, 2022
Figure 16. Global Medical Autologous Biologics Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Medical Autologous Biologics Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Medical Autologous Biologics Production Market Share & Forecast by Region, 2018-2029
Figure 19. Medical Autologous Biologics Industry Chain
Figure 20. Medical Autologous Biologics Procurement Model
Figure 21. Medical Autologous Biologics Sales Model
Figure 22. Medical Autologous Biologics Sales Channels, Direct Sales and Distribution
Figure 23. Adipose Tissue
Figure 24. Plasma
Figure 25. Others
Figure 26. By Type, Global Medical Autologous Biologics Revenue, 2018-2029, US$ Million
Figure 27. By Type, Global Medical Autologous Biologics Revenue Market Share, 2018-2029
Figure 28. By Type, Global Medical Autologous Biologics Sales Volume, 2018-2029, (Kg)
Figure 29. By Type, Global Medical Autologous Biologics Sales Volume Market Share, 2018-2029
Figure 30. By Type, Global Medical Autologous Biologics Price, 2018-2029, (US$/g)
Figure 31. Hospitals
Figure 32. Research Center
Figure 33. Others
Figure 34. By Application, Global Medical Autologous Biologics Revenue, 2018-2029, US$ Million
Figure 35. By Application, Global Medical Autologous Biologics Revenue Market Share, 2018-2029
Figure 36. By Application, Global Medical Autologous Biologics Sales Volume, 2018-2029, (Kg)
Figure 37. By Application, Global Medical Autologous Biologics Sales Volume Market Share, 2018-2029
Figure 38. By Application, Global Medical Autologous Biologics Price, 2018-2029, (US$/g)
Figure 39. By Region, Global Medical Autologous Biologics Revenue Market Share, 2018-2029
Figure 40. By Region, Global Medical Autologous Biologics Sales Volume Market Share, 2018-2029
Figure 41. North America Medical Autologous Biologics Revenue & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, North America Medical Autologous Biologics Revenue Market Share, 2022
Figure 43. Europe Medical Autologous Biologics Revenue & Forecasts, 2018-2029, US$ Million
Figure 44. By Country, Europe Medical Autologous Biologics Revenue Market Share, 2022
Figure 45. Asia Pacific Medical Autologous Biologics Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country/Region, Asia Pacific Medical Autologous Biologics Revenue Market Share, 2022
Figure 47. South America Medical Autologous Biologics Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country, South America Medical Autologous Biologics Revenue Market Share, 2022
Figure 49. Middle East & Africa Medical Autologous Biologics Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. U.S. Medical Autologous Biologics Sales Volume, 2018-2029, (Kg)
Figure 51. By Company, U.S. Medical Autologous Biologics Market Share, 2022
Figure 52. By Type, U.S. Medical Autologous Biologics Sales Volume Market Share, 2022 VS 2029
Figure 53. By Application, U.S. Medical Autologous Biologics Sales Volume Market Share, 2022 VS 2029
Figure 54. Europe Medical Autologous Biologics Sales Volume, 2018-2029, (Kg)
Figure 55. By Company, Europe Medical Autologous Biologics Market Share, 2022
Figure 56. By Type, Europe Medical Autologous Biologics Sales Volume Market Share, 2022 VS 2029
Figure 57. By Application, Europe Medical Autologous Biologics Sales Volume Market Share, 2022 VS 2029
Figure 58. China Medical Autologous Biologics Sales Volume, 2018-2029, (Kg)
Figure 59. By Company, China Medical Autologous Biologics Market Share, 2022
Figure 60. By Type, China Medical Autologous Biologics Sales Volume Market Share, 2022 VS 2029
Figure 61. By Application, China Medical Autologous Biologics Sales Volume Market Share, 2022 VS 2029
Figure 62. Japan Medical Autologous Biologics Sales Volume, 2018-2029, (Kg)
Figure 63. By Company, Japan Medical Autologous Biologics Market Share, 2022
Figure 64. By Type, Japan Medical Autologous Biologics Sales Volume Market Share, 2022 VS 2029
Figure 65. By Application, Japan Medical Autologous Biologics Sales Volume Market Share, 2022 VS 2029
Figure 66. South Korea Medical Autologous Biologics Sales Volume, 2018-2029, (Kg)
Figure 67. By Company, South Korea Medical Autologous Biologics Market Share, 2022
Figure 68. By Type, South Korea Medical Autologous Biologics Sales Volume Market Share, 2022 VS 2029
Figure 69. By Application, South Korea Medical Autologous Biologics Sales Volume Market Share, 2022 VS 2029
Figure 70. Southeast Asia Medical Autologous Biologics Sales Volume, 2018-2029, (Kg)
Figure 71. By Company, Southeast Asia Medical Autologous Biologics Market Share, 2022
Figure 72. By Type, Southeast Asia Medical Autologous Biologics Sales Volume Market Share, 2022 VS 2029
Figure 73. By Application, Southeast Asia Medical Autologous Biologics Sales Volume Market Share, 2022 VS 2029
Figure 74. India Medical Autologous Biologics Sales Volume, 2018-2029, (Kg)
Figure 75. By Company, India Medical Autologous Biologics Market Share, 2022
Figure 76. By Type, India Medical Autologous Biologics Sales Volume Market Share, 2022 VS 2029
Figure 77. By Application, India Medical Autologous Biologics Sales Volume Market Share, 2022 VS 2029
Figure 78. Middle East & Asia Medical Autologous Biologics Sales Volume, 2018-2029, (Kg)
Figure 79. By Company, Middle East & Asia Medical Autologous Biologics Market Share, 2022
Figure 80. By Type, Middle East & Asia Medical Autologous Biologics Sales Volume Market Share, 2022 VS 2029
Figure 81. By Application, Middle East & Asia Medical Autologous Biologics Sales Volume Market Share, 2022 VS 2029
Figure 82. Research Methodology
Figure 83. Breakdown of Primary Interviews
Figure 84. Bottom-up Approaches
Figure 85. Top-down Approaches
Research Methodology:
Medical Autologous Biologics Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|